McWherter Charles
- SEC CIK
- 0001588862
No open-market purchases or sales filed in the past year.
Current role at each company
- ETNB 89bio, Inc.Directoras of Oct 30, 2025
- CBAY CymaBay Therapeutics, Inc.President of R&Das of Mar 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McWherter Charles as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ETNB 89bio, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 (view filing) | Jan 21-22 | 2 days | McWherter CharlesDirector | PPurchase | +15.0K | $6.66 | +$99.8K | +150.0%25.0K after | 2 lots |
| Dec 9, 2024 (view filing) | Dec 5 | 4 days | McWherter CharlesDirector | PPurchase | +10.0K | $8.00 | +$80.0K | New position10.0K after |
CBAY CymaBay Therapeutics, Inc.
President of R&D9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2024 (view filing) | Jan 19 | 3 days | McWherter CharlesPresident of R&D | SSale | −18.4K | $23.67 | −$435.7K | −55.1%15.0K after | 5 lots10b5-1 |
| Dec 18, 2023 (view filing) | Dec 18 | Same day | McWherter CharlesPresident of R&D | SSale | −11.3K | $21.48 | −$243.5K | −43.0%15.0K after | 2 lots |
| Nov 17, 2023 (view filing) | Nov 17 | Same day | McWherter CharlesPresident of R&D | SSale | −11.3K | $18.28 | −$207.3K | −43.1%15.0K after | |
| Oct 18, 2023 (view filing) | Oct 18 | Same day | McWherter CharlesPresident of R&D | SSale | −21.7K | $14.07 | −$305.9K | −59.2%15.0K after | |
| Sep 19, 2023 (view filing) | Sep 18 | 1 day | McWherter CharlesPresident of R&D | SSale | −21.7K | $16.22 | −$352.7K | −59.2%15.0K after | |
| Aug 18, 2023 (view filing) | Aug 18 | Same day | McWherter CharlesPresident of R&D | SSale | −21.7K | $11.47 | −$249.4K | −59.2%15.0K after | |
| Jul 19, 2023 (view filing) | Jul 18 | 1 day | McWherter CharlesPresident of R&D | SSale | −21.7K | $11.43 | −$248.6K | −59.2%15.0K after | |
| Jun 21, 2023 (view filing) | Jun 20 | 1 day | McWherter CharlesPresident of R&D | SSale | −21.7K | $8.16 | −$177.5K | −59.2%15.0K after | |
| May 19, 2023 (view filing) | May 18 | 1 day | McWherter CharlesPresident of R&D | SSale | −21.7K | $9.08 | −$197.5K | −59.2%15.0K after |